Meta-analysis as a clinical tool in nephrology

Kidney International

Volumn 53, Issue 4, 1998, Pages 819-825

  Kasiske, Bertram L ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Clinical trials; Kidney disease; Randomized controlled trials; Systemic reviews

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL; HUMAN; MEDICAL RESEARCH; META ANALYSIS; NEPHROLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0031958744     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.1998.00859.x     Document Type: Article

References (58)

1. COOK DJ, MULROW CD, HAYNES RB: Systematic reviews: Synthesis of best evidence for clinical decisions. Ann Intern Med 126:376-380, 1997
2. GLASS GV: Primary, secondary, and meta-analysis. Educational Researcher 5:3-8, 1976
3. PEARSON K: Report on certain enteric fever inoculation statistics. Br Med J 3:1243-1246, 1904
4. BAILAR JD III: The promise and problems of meta-analysis. (editorial; comment) N Engl J Med 337:559-561, 1997
5. The Handbook of Research Synthesis. New York, Russell Sage Foundation, 1994
6. GLASS GV, MCGAW B, SMITH ML: Meta-Analysis in Social Research. Beverly Hills, Sage Publications, 1981
7. BUSHMAN BJ: Vote-counting procedures in meta-analysis, in The Handbook of Research Synthesis, edited by COOPER H, HEDGES LV, New York, Russell Sage Foundation, 1994, p 193
8. DERSIMONIAN R, LAIRD N: Meta-analysis in clinical trials. Controlled Clin Trials 7:177-188, 1986
9. LOUIS TA: Meta-analysis of clinical studies: The whole is greater than the sum of its parts. (editorial) Transfusion 33:698-700, 1993
10. HARDY RJ, THOMPSON SG: A likelihood approach to meta-analysis with random effects. Stat Med 15:619-629, 1996
11. LOUIS TA, ZELTERMAN D: Bayesian approaches to research synthesis, in The Handbook of Research Synthesis, edited by COOPER H. HEDGES LV, New York, Russell Sage Foundation, 1994, p 411
12. LELORIER J, GREGOIRE G, BENHADDAD A, LAPIERRE J, DERDERIAN F: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 337:536-542, 1997
13. BORZAK S, RIDKER PM: Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med 123:873-877, 1997
14. YUSUF S, COLLINS R, MACMAHON S, PETO R: Effect of intravenous nitrates on mortality in acute myocardial infarction: An overview of the randomised trials. Lancet 1:1088-1092, 1988
15. GRUPPO ITALIANO PER LO STUDIO DELLA SOPRAVVIVENZA NELL'INFARTO MIOCARDICO: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 343:1115-1122, 1994
16. FOURTH INTERNATIONAL STUDY OF INFARCT SURVIVAL COLLABORATIVE GROUP: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345:669-685, 1995
17. CAPPELLERI JC, IOANNIDIS JPA, SCHMID CH, DE FERRANTI SD, AUBERT M, CHALMERS TC, LAU J: Large trials vs meta-analysis of smaller trials. How do their results compare? JAMA 276:1332-1338, 1996
18. EASTERBROOK PJ, BERLIN JA, GOPALAN R, MATHEWS DR: Publication bias in clinical research. Lancet 337:867-872, 1991
19. DICKERSIN K, MIN Y-L, MEINERT CL: Factors influencing publication of research results: Follow-up of applications submitted to two institutional review boards. JAMA 267:374-378, 1992
20. LIGHT RJ, PILLEMER DB: Summing Up: The Science of Reviewing Research. Cambridge, Harvard University Press, 1984
21. BEGG CB, MAZUMDAR M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101, 1994
22. ROSENTHAL R: The "file-drawer problem" and tolerance for null results. Psychol Bull 86:638-641, 1979
23. GREGOIRE G, DERDERIAN F, LELORIER J: Selecting the language of the publications included in a meta-anslysis: Is there a Tower of Babel bias? J Clin Epidemiol 48:159-163, 1995
24. LAU J, ANTMAN EM, JIMENEZ-SILVA J, KUPELNICK B, MOSTELLER F, CHALMERS TC: Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327:248-254, 1992
25. LAU J, SCHMID CH, CHALMERS TC: Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 48:45-57, 1995
26. KASISKE BL, KALIL RSN, MA JZ, LIAO M, KEANE WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118:129-138, 1993
27. MAKI DD, MA JZ, LOUIS TA, KASISKE BL: Long-term effects of antihypertensive agents on proteinuria and renal function. Arch Intern Med 155:1073-1080, 1995
28. DE JONG PE, HEEG JE, APPERLOO AJ, DE ZEEUW D: The antiproteinuric effects of blood pressure-lowering agents: Differences between nondiabetics and diabetics. J Cardiovasc Pharmacol 19(Suppl 6):S28-S32, 1992
29. GANSEVOORT RT, SLUITER WJ, HEMMELDER MH, DE ZEEUW D, DE JONG PE: Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials. Nephrol Dial Transplant 10:1963-1974, 1995
30. BÖHLEN L, DE COURTEN M, WEIDMANN P: Comparative study of the effect of ACE-inhibitors and other antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 7:84S-92S, 1994
31. BERGEMANN R, WOHLER D, WEIDMANN P, BETZIN J, NAWRATH T: Verbesserte glucoseeinstellung und mikroalbuminurie/proteinurie bei diabetikern unter ACE-hemmer-behandlung. Schweiz Med Wochenschr 122:1369-1376, 1992
32. GIATRAS I, LAU J, LEVEY AS, FOR THE ANGIOTENSIN-CONVERTING-ENZYME INHIBITION, PROGRESSIVE RENAL DISEASE STUDY GROUP: Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Ann Intern Med 127:337-345, 1997
33. VOLHARD F: Die doppelseitigen hämatogenen Nierenerkrankungen (Bright'sche Krankheit), in Handbuch der Inneren Medizin, edited by MOHR, STAEHELIN, Berlin, Springer Verlag, 1918, p S1149
34. FOUQUE D, LAVILLE M, BOISSEL JP, CHIFFLET R, LABEEUW M, ZECH PY: Controlled low protein diets in chronic renal insufficiency: Meta-analysis. Br Med J 304:216-220, 1992
35. KLAHR S, LEVEY AS, BECK GJ, CAGGIULA AW, HUNSICKER L. KUSEK JW, STRIKER G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:877-884, 1994
36. PEDRINI MT, LEVEY AS, LAU J, CHALMERS TC, WANG PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis. Ann Intern Med 124:627-632, 1996
37. COUCHOUD C, LAVILLE M, BOISSEL JP: Treatment of membranous nephropathy: A meta-analysis. Nephrol Dial Transplant 9:469-470, 1994
38. IMPERIALE TF, GOLDFARB S, BERNS JS: Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials. J Am Soc Nephrol 5:1553-1558, 1995
39. HOGAN SL, MULLER KE, JENNETTE JC, FALK RJ: A review of therapeutic studies of idiopathic membranous glomerulopathy. Am J Kidney Dis 25:862-875, 1995
40. FELSON DT, ANDERSON J: Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis. N Engl J Med 311:1528-1533, 1984
41. BANSAL VK, BETO JA: Treatment of lupus nephritis: A meta-analysis of clinical trials. Am J Kidney Dis 29:193-199, 1997
42. SCHENA FP, MONTENEGRO M, SCIVITTARO V: Meta-analysis of randomised controlled trials in patients with primary IgA nephropathy (Berger's Disease). Nephrol Dial Transplant 5(Suppl 1):47-52, 1990
43. BLAUFOX MD, MIDDLETON ML, BONGIOVANNI J, DAVIS BR: Cost efficacy of the diagnosis and therapy of renovascular hypertension. J Nucl Med 37:171-177, 1996
44. NAYLOR CD, DETSKY AS, O'ROURKE K, FONBERG E: Does treatment with essential amino acids and hypertonic glucose improve survival in acute renal failure?: A meta-analysis. Renal Fail 10:141-152, 1987
45. BARRETT BJ, CARLISLE EJ: Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 188:171-178, 1993
46. GLOWACKI LS, SMAILL FM: Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients - A meta-analysis. Clin Transplant 8:10-18, 1994
47. WALKER AM, WILKINSON GS, ZAWEL J, LANES SF: Treatment efficacy of cyclosporine in renal transplantation. J Clin Res Pharmacoepidemiol 4:161-173, 1990
48. CARRIER M, JENICEK M, PELLETIER LC: Value of monoclonal antibody OKT3 in solid organ transplantation: A meta-analysis. Transplant Proc 24:2586-2591, 1992
49. KASISKE BL, HEIM-DUTHOY K, MA JZ: Elective cyclosporine withdrawal after renal transplantation. A meta-analysis. JAMA 269:395-400, 1993
50. HRICIK DE, O'TOOLE MA, SCHULAK JA, HERSON J: Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 4:1300-1305, 1993
51. KASISKE BL, MA JZ, LOUIS TA, SWAN SK: Long-term effects of reduced renal mass in humans. Kidney Int 48:814-819, 1995
52. PERNA A, REMUZZI G: Abnormal permeability to proteins and glomerular lesions: A meta-analysis of experimental and human studies. Am J Kidney Dis 27:34-41, 1996
53. LEIBOVICI L, WYSENBEEK AJ: Single-dose treatment of urinary tract infections with and without antibody-coated bacteria: A meta-analysis of controlled trials. (letter) J Infect Dis 163:928-929, 1991
54. JERNIGAN JA, FARR BM: Short-course therapy of catheter-related Staphylococcus aureus bacteremia: A meta-analysis. Ann Intern Med 119:304-311, 1993
55. KELLER F, ERDMANN K, GIEHL M, BUETTNER P: Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin. Clin Pharmacokinet 25:71-79, 1993
56. LABRECOUE M, DOSTALER LP, ROUSSELLE R, NGUYEN T, POIRIER S: Efficacy of nonsteroidal anti-inflammatory drugs in the treatment of acute renal colic. A meta-analysis. Arch Intern Med 154:1381-1387, 1994
57. RAO JK, WEINBERGER M, ODDONE EZ, ALLEN NB, LANDSMAN P, FEUSSNER JR: The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med 123:925-932, 1995
58. MASSY ZA, MA JZ, LOUIS TA, KASISKE BL: Lipid-lowering therapy in patients with renal disease. Kidney Int 48:188-198, 1995